EUVIMEDEUVIMED entdecken
Fall-Kontroll-StudieOpen Access · CC BY 4.0

Serum trough concentration threshold and risk factors of cefoperazone-induced coagulopathy in critically ill patients: A retrospective case-control study

Qian Wang, Pei Liang, Ying Xu, Binbin Yuan, Chen Lan, Xiaodi Yan, Li Li

European Journal of Clinical Pharmacology · 2024

DOI: 10.1007/s00228-024-03634-4 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift European Journal of Clinical Pharmacology, 2024. Verfasst von Qian Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Nanjing Drum Tower Hospital, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangs…. Hauptthemen laut MEDLINE: Blood Coagulation Disorders, Liver Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To analyze the risk factors influencing the development of cefoperazone-induced coagulopathy in critically ill patients and determine the threshold of serum trough concentration.

Methods

A retrospective case-control study was conducted in the intensive care unit patients treated with cefoperazone, and it was approved by the Ethical Committee of Drum Tower Hospital affiliated with the Medical School of Nanjing University (NO.2023-158-01). Patients were divided into the normal group and coagulopathy group based on prothrombin time. The clinical characteristics of the two groups were compared using univariate analysis. The serum concentration threshold and influencing factors of cefoperazone-induced coagulopathy in critically ill patients were analyzed using the receiver operating characteristic curve and multivariate logistic regression analysis.

Results

A total of 113 patients were included, and cefoperazone-induced coagulopathy occurred in 39 patients, with an incidence of 34.5%. These patients experienced significant prothrombin time prolongation around day 6 (median) after cefoperazone application. The serum trough concentration threshold of cefoperazone-induced coagulopathy in critically ill patients was 87.765 mg/l. Multivariate logistic regression analysis revealed that the APACHE II score ( p = 0.034), prophylactic use of vitamin K 1 ( p < 0.001), hepatic impairment ( p = 0.014), and C min ≥ 87.765 mg/l ( p = 0.005) were associated with cefoperazone-induced coagulopathy.

Conclusion

Cefoperazone-induced coagulopathy usually occurs on the 6th day of cefoperazone use in critically ill patients. The risk will increase in patients with an APACHE II score > 25, hepatic impairment, and cefoperazone C min ≥ 87.765 mg/l. Vitamin K 1 is effective in preventing this adverse reaction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood Coagulation DisordersLiver DiseasesHumansCefoperazoneCase-Control StudiesRetrospective StudiesCritical IllnessRisk FactorsVitamin KIntensive Care Units

Stichwörter der Autor:innen

CefoperazoneCoagulopathyRisk factorsSerum trough concentration

Substanzen

CefoperazoneVitamin K

Autor:innen und Institutionen

  • Department of Pharmacy, Nanjing Drum Tower Hospital, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China.
  • School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China.
  • Department of Pharmacy, Drum Tower Hospital Affiliated to Medical School of Nanjing University, Nanjing, Jiangsu, China.
  • Intensive Care Unit, Drum Tower Hospital Affiliated to Nanjing University School of Medicine, Nanjing, Jiangsu, China.
  • Department of Pharmacy, Drum Tower Hospital Affiliated to Medical School of Nanjing University, Nanjing, Jiangsu, China. njgllily@163.com.

Zitieren

APA

Wang, Q., Liang, P., Xu, Y., Yuan, B., Lan, C., Yan, X., & Li, L. (2024). Serum trough concentration threshold and risk factors of cefoperazone-induced coagulopathy in critically ill patients: A retrospective case-control study. European Journal of Clinical Pharmacology. https://doi.org/10.1007/s00228-024-03634-4

Vancouver

Wang Q, Liang P, Xu Y, Yuan B, Lan C, Yan X, et al. Serum trough concentration threshold and risk factors of cefoperazone-induced coagulopathy in critically ill patients: A retrospective case-control study. European Journal of Clinical Pharmacology. 2024. doi:10.1007/s00228-024-03634-4

BibTeX
@article{Wang2024,
  author = {Wang, Qian and Liang, Pei and Xu, Ying and Yuan, Binbin and Lan, Chen and Yan, Xiaodi and Li, Li},
  title = {Serum trough concentration threshold and risk factors of cefoperazone-induced coagulopathy in critically ill patients: A retrospective case-control study},
  journal = {European Journal of Clinical Pharmacology},
  year = {2024},
  doi = {10.1007/s00228-024-03634-4}
}
Kostenlos starten →